Back to results
US 2016/0243253 A1Published application
Tolerogenic synthetic nanocarriers
AssigneeSelecta Biosciences, Inc.
InventorsChristopher Fraser, Grayson B. Lipford, Christopher J. Roy, Roberto A. Maldonado
Life of this patent
Estimating the term…
Abstract
This invention relates, at least in part, to compositions comprising synthetic nanocarriers and immunosuppressants that result in immune suppressive effects. Such compositions can further comprise antigen and provide antigen-specific tolerogenic immune responses.
Claims22
A composition comprising:
- (i) a first population of synthetic nanocarriers coupled to an immunosuppressant, and
- (ii) an APC presentable antigen.
19-26. (canceled)
29-44. (canceled)
Dependencies are inferred from the claim text.